Video

The Integration of Complementary Cancer Care May ‘Accelerate’ in Coming Years, Says Patrick Dempsey

Author(s):

Actor and cancer advocate Patrick Dempsey predicts that more focus will be put on complementary cancer care, such as nutrition and environmental factors, over the next several years.

The future of cancer care may revolve around a more integrative approach, according to actor, producer and cancer advocate, Patrick Dempsey.

Dempsey, who delivered the keynote address at CURE®’s 2022 Extraordinary Healer® award for oncology nursing ceremony, also mentioned that mental health will also continue to be a bigger focus in oncology as well.

Transcription

I think the health care providers are going to be big (players in) how we approach caring for patients, and in hospitals in general can be much more specific. You’re starting to see that already.

And the integration complementary care, understanding that nutrition, environment, all of those things are going to … see an acceleration in the next 20 years of how we approach it.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Related Content